13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Rebalancing commercial and public interests in prioritizing biomedical, social and environmental aspects of health through defining and managing conflicts of interest

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Abstract Biomedical research is intended to benefit human beings and their health. Toward that end, scientific norms involve examining and criticizing the work of others and prioritizing questions that should be studied. Yet, in areas of health research where industry is active, it has often utilized well-honed strategies aimed at evading scientific standards and at dominating the research agenda, largely through its financial support and lack of transparency of its research practices. These tactics have now been documented to uniformly support industry products. Commercial entities are aided in this pursuit by public policy that has significantly embedded commercial interests and agendas into federal research funding and infrastructure. Therefore, to understand the resulting landscape and its effect on priority in health research agendas, traditional definitions of individual conflicts of interest (COI) and the less well developed institutional COI must be supplemented by a new construct of structural COI, largely operating as intellectual monopolies, in support of industry. These arrangements often result in financial and reputational resources that assure dominance of commercial priorities in research agendas, crowding out any other interests and ignoring justified returns to the public from investment of its tax dollars. There is no sustained attention to mechanisms by which public interests can be heard, normative issues raised, and then balanced with commercial interests which are transparently reported. Focus on research supporting approval of commercial products ignores social and environmental determinants of health. Commercial bias can invalidate regulatory research protections through obscuring valid risk–benefit ratios considered by IRBs.

          Related collections

          Most cited references81

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Time to challenge the spurious hierarchy of systematic over narrative reviews?

          Key point Systematic reviews are generally placed above narrative reviews in an assumed hierarchy of secondary research evidence We argue that systematic reviews and narrative reviews serve different purposes and should be viewed as complementary Conventional systematic reviews address narrowly focused questions; their key contribution is summarising data Narrative reviews provide interpretation and critique; their key contribution is deepening understanding 1 BACKGROUND Cynthia Mulrow's important paper calling for literature reviews to be undertaken more systematically (and hence be more informative and reliable) is now 30 years old.1 A recent paper in BMC Medical Research Methodology compared the proportion of reviews that were systematic (as opposed to narrative) in five leading biomedical journals.2 The authors found significant diversity: from New England Journal of Medicine (0%) and Lancet (11%) to Annals of Internal Medicine (72%). Systematic reviews were assumed by the authors to be superior because they are (i) more likely to have a focused research question, (ii) more methodologically explicit and (iii) less likely to be biased than narrative reviews. This stance reflects the raison d’être of the Cochrane Collaboration, whose use of explicit and auditable quality criteria for undertaking systematic reviews has inspired a weighty methodological handbook,3 numerous tools and checklists4, 5 and structured reporting criteria.6 There is strong emphasis on methodological reproducibility, with the implication that a different review team, using the same search criteria, quality checklists and synthesis tools, should obtain the same result.3 Yet leading medical journals regularly publish clinical topic reviews that may lack a focused research question, methods section or statement on how studies were selected and analysed (see for example7, 8, 9). These narrative reviews typically draw on expert opinion by deliberately recruiting leading names in the field (eg “The aim of this Commission is to provide the strongest evidence base through involvement of experts from a wide cross‐section of disciplines…”—page 1953, emphasis added8). Reviews crafted through the experience and judgement of experts are often viewed as untrustworthy (“eminence‐based” is a pejorative term). Yet the classical definition of the EBM as “the conscientious, explicit, and judicious use of current best evidence …” (page 71, emphasis added)10 suggests a key role for judgement in the selection and interpretation of evidence. In short, there appears to be a growing divergence between the assumed “hierarchy” of evidence in secondary research, which defines systematic reviews as superior,11 and what some leading academic journals view as a state‐of‐the‐art (that is, expert‐led narrative) review. We believe this is partly because the systematic review format has been erroneously defined as a universal gold standard and partly because the term “narrative review” is frequently misunderstood, misapplied and unfairly dismissed. Systematic reviews in the Cochrane sense use a highly technical approach to identification, appraisal and synthesis of evidence and typically (although not invariably) privilege randomised controlled trials or previous systematic reviews over other forms of evidence.11 This may be entirely appropriate—especially when the primary purpose is to answer a very specific question about how to treat a particular disease in a particular target group. But the doctor in the clinic, the nurse on the ward or the social worker in the community will encounter patients with a wide diversity of health states, cultural backgrounds, illnesses, sufferings and resources.12 And those who gather around the policymaking table will find multiple calls on their attention—including burden of need, local availability of different treatments, personal testimony, strength of public opinion and budgetary realities. To produce a meaningful synthesis of research evidence relevant to such complex situations, the reviewer must (i) incorporate a broad range of knowledge sources and strategies for knowing and (ii) undertake multi‐level interpretation using creativity and judgement.12, 13 We align with previous authors, who, drawing on Wittgenstein, distinguish between puzzles or problems that require data (for which a conventional systematic review, with meta‐analysis where appropriate, may be the preferred methodology) and those that require clarification and insight (for which a more interpretive and discursive synthesis of existing literature is needed).14, 15 Below, we explore both strengths, limitations and conceptual confusions of systematic and narrative reviews. We consider three questions: what makes a review systematic; what is a narrative review and whether these different kinds of review should be viewed as competing or complementary. 2 WHAT MAKES A REVIEW SYSTEMATIC? The defining characteristic of a systematic review in the Cochrane sense is the use of a predetermined structured method to search, screen, select, appraise and summarise study findings to answer a narrowly focused research question.3, 16 Using an exhaustive search methodology, the reviewer extracts all possibly relevant primary studies, and then limits the dataset using explicit inclusion and exclusion criteria. The review focus is highly circumscribed and quality criteria are tightly enforced. Typically, a body of hundreds or thousands of potential studies identified in the initial search is whittled down to a mere handful before the reviewer even begins to consider what they collectively mean. The term “systematic” is thus by no means synonymous with “high‐quality”. Rather, it can be viewed as a set of methodologies characterised by tight focus, exhaustive search, high rejection‐to‐inclusion ratio and an emphasis on technical rather than interpretive synthesis methods. The conflation of the quality of a review with the assiduousness of such tasks as searching, applying inclusion and exclusion criteria, creating tables of extracted data and mathematically summing effect sizes (rather than, for example, with the level of critical analysis of the papers’ unstated assumptions and discussion sections) has, we believe, led to a proliferation of systematic reviews that represent aggregations of findings within the narrow body of work that has met the authors’ eligibility criteria.17, 18, 19 Such studies may sometimes add value, especially when additional meta‐analysis confirms whether a clinically significant effect is or is not also statistically significant.20 But sometimes, the term “systematic review” allows a data aggregation to claim a more privileged position within the knowledge hierarchy than it actually deserves.11 We acknowledge that the science of systematic review within the Cochrane and Campbell Collaborations is evolving to embrace a wider range of primary studies and methodologies, with recommended procedures for sampling, assessment and synthesis of evidence compliant with the question asked and the context explored. The adjective “systematic” is thus coming to acquire a broader meaning in terms of the transparency and appropriateness of methods, rather than signifying strict adherence to a particular pre‐defined tool or checklist or a privileging of randomised trials (see for example methodological work by Lewin et al,21 Petticrew et al22 and Pluye et al23, 24, 25). All these approaches, however, remain focused on answering a relatively narrow question that is predefined at the outset and with a primary focus on the extraction, tabulation and summation of empirical data. 3 WHAT IS A NARRATIVE REVIEW? A narrative review is a scholarly summary along with interpretation and critique.26 It can be conducted using a number of distinctive methodologies. While principles and procedures may diverge from the classic methodology of systematic review, they are not unsystematic (in the sense of being ad hoc or careless), and may certainly be conducted and presented in a systematic way, depending on purpose, method and context. Different kinds of reviews offer different kinds of truth: the conventional systematic review with meta‐analysis deals in probabilistic (typically, Bayesian) truth; it is concerned mainly with producing generalisable “facts” to aid prediction. The narrative review, in contrast, deals in plausible truth. Its goal is an authoritative argument, based on informed wisdom that is convincing to an audience of fellow experts. To that end, the author of a narrative review must authentically represent in the written product both the underpinning evidence (including but not limited to primary research) and how this evidence has been drawn upon and drawn together to inform the review's conclusions. A hermeneutic review takes as its reference point the notion of verstehen, or the process of creating an interpretive understanding.14 It capitalises on the continual deepening of insight that can be obtained by critical reflection on particular elements of a dataset—in this case, individual primary studies—in the context of a wider body of work. It may or may not define its reference body of studies using systematic search methods and inclusion/exclusion criteria, but its primary focus is on the essential tasks of induction and interpretation in relation to the defined sample for the purpose of advancing theoretical understanding.17 A realist review considers the “generative causality,” in which particular mechanisms (for example, peer influence) produce particular outcomes (for example, smoking cessation) in some circumstances (for example, when societal disapproval of smoking is high) but not others (for example, in cultures where smoking is still widely viewed as a mark of sophistication).27 A meta‐narrative review maps the storyline of a research tradition over time.28 Shifting the focus away from comparing findings of studies published at different times, it orients critical reflection to discern how ideas have waxed and waned within different scholarly communities at different points in the development of thinking (see an early example of how the term “diffusion of innovations” was differently defined and explored in different academic disciplines29). Each of these forms of narrative review (along with other specialist approaches to combining primary studies in qualitative research30, 31) reflects an explicit lens that is expected to shape the understandings that will arise from the review process, through analysis and synthesis processes that may be highly systematic. Narrative reviews also include a number of more generic styles such as integrative32, 33 and critical,34 the former being the approach generally taken by narrative reviews in clinical journals. All these approaches play an important role in expanding our understanding not only of the topic in question but also of the reasons why it has been studied in a particular way, the interpretations that have been variously made with respect to what we know about it, and the nature of the knowledge base that informs or might inform clinical practice. Because hermeneutic, realist and meta‐narrative reviews have explicit methodologies and accepted standards and criteria for judging their quality,14, 27, 28 a minority of scholars include such approaches within the (broadly defined) category of systematic reviews. However, we have had experience of journal editors rejecting reviews based on these techniques on the grounds that they were “not systematic”. Also of note is the emergence of “how‐to” guides for narrative reviews, which (misleadingly in our view) exhort the reviewer to focus carefully on such tasks as starting with an explicit search strategy and defining strict inclusion and exclusion criteria for primary studies.35, 36 In other words, the boundaries between systematic and narrative reviews are both fuzzy and contested. 4 SYSTEMATIC OR NARRATIVE OR SYSTEMATIC AND NARRATIVE? The conflation of “systematic” with superior quality (and “narrative” with inferior quality) has played a major role in the muddying of methodological waters in secondary research. This implicit evidence hierarchy (or pyramid) elevates the mechanistic processes of exhaustive search, wide exclusion and mathematical averaging over the thoughtful, in‐depth, critically reflective processes of engagement with ideas. The emphasis on thinking and interpretation in narrative review has prompted some authors to use the term “evidence‐informed” rather than “evidence‐based”15, 37: the narrative review is both less and more than a methods‐driven exercise in extracting and summating data. Training in systematic reviews has produced a generation of scholars who are skilled in the technical tasks of searching, sorting, checking against inclusion criteria, tabulating extracted data and generating “grand means” and confidence intervals.3 These skills are important, but as the recent article by Faggion et al illustrates, critics may incorrectly assume that they override and make redundant the generation of understanding. To the extent that the term “systematic review” privileges only that which is common in the findings amongst a rigidly defined subset of the available body of work, we risk losing sight of the marvellous diversities and variations that ought to intrigue us. In excluding those aspects of scholarship, systematic reviews hold the potential to significantly skew our knowledge landscape. While there are occasions when systematic review is the ideal approach to answering specific types of question, the absence of thoughtful, interpretive critical reflection can render such products hollow, misleading and potentially harmful. The argument that systematic reviews are less biased than narrative reviews begs the question of what we mean by bias. Bias is an epidemiological construct, which refers to something that distorts the objective comparisons between groups.20 It presupposes the dispassionate, instrumental and universal “view from nowhere” that has long defined the scientific method.38 When we speak of interpretation, we refer to an analysis that is necessarily perspectival, with the interpreter transparently positioned in order that the reader can understand why this particular perspective, selection process and interpretive methodology was selected in relation to the question at hand.14, 17, 29, 37, 39 Systematic and transparent reflection upon and sharing of such aspects of the research process adds to the scientific quality of interpretive research. The question of whether “systematic” review techniques can eliminate bias in secondary research is in any case questionable. The privileging of freedom from bias over relevance of question and findings wrongly assumes that how the topic is framed, and which questions should be explored is somehow self‐evident. A recent review of systematic reviews generated by a national knowledge centre to inform policymaking in Norway showed that in most cases, the evidence base addressed only a fraction of relevant policy questions.40 More generally, there is growing evidence that the science of systematic reviews is becoming increasingly distorted by commercial and other conflicts of interest, leading to reviews, which—often despite ticking the boxes on various quality checklists—are unnecessary, misleading or partisan.19, 41 The holy grail of a comprehensive database of unambiguous and unbiased evidence summaries (in pursuit of which the Cochrane Collaboration was founded42) continues to recede into the future. A legitimate criticism of narrative reviews is that they may “cherry pick” evidence to bolster a particular perspective. But this must be weighed against the counter‐argument that the narrative reviewer selects evidence judiciously and purposively with an eye to what is relevant for key policy questions—including the question of which future research programmes should be funded. Whilst we accept that narrative reviews can be performed well or badly, we believe the undervaluing of such reviews is a major contributor to research waste. In the absence of an interpretive overview of a topic that clearly highlights the state of knowledge, ignorance and uncertainty (explaining how we know what we know, and where the intriguing unanswered questions lie), research funding will continue to be ploughed into questions that are of limited importance, and which have often already been answered.40 This principle was illustrated in a recent hermeneutic review of telehealth in heart failure by one of us.43 It identified 7 systematic reviews of systematic reviews, 32 systematic reviews (including 17 meta‐analyses) covering hundreds of primary studies, as well as six mega‐trials—almost all of which had concluded that more research (addressing the same narrow question with yet more randomised trials intended to establish an effect size for telehealth) was needed. The hermeneutic approach revealed numerous questions that had remained under‐explored as researchers had pursued this narrow question—including the complex and changing nature of the co‐morbidities and social determinants associated with heart failure, the varied experiences and priorities of patients with heart failure, the questionable nature of up‐titration as a guiding principle in heart failure management, and the numerous organisational, regulatory and policy‐level complexities associated with introducing telehealth programmes. The review concluded that: “The limited adoption of telehealth for heart failure has complex clinical, professional and institutional causes, which are unlikely to be elucidated by adding more randomised trials of technology‐on versus technology‐off to an already‐crowded literature. An alternative approach is proposed, based on naturalistic study designs, application of social and organisational theory, and co‐design of new service models based on socio‐technical principles” (page 156). 5 CONCLUSION As many authors and journal editors are well aware, the narrative review is not a poor cousin of the systematic review but a different and potentially complementary form of scholarship.22, 44 Nevertheless, the simplistic hierarchy “systematic review good; narrative review less good” persists in some circles. The under‐acknowledged limitations of systematic reviews, along with missed opportunities for undertaking and using narrative reviews to extend understanding within a field, risks legitimising and perpetuating a narrow and unexciting research agenda and contributing to research waste. We call upon policymakers and clinicians (who seek to ensure that their decisions are evidence‐based, but who may have been seduced by a spurious hierarchy of secondary evidence) and on research commissioners (whose decisions will shape the generation of the future evidence base) to re‐evaluate the low status currently afforded to narrative reviews. AUTHORS’ CONTRIBUTIONS TG was invited to submit a paper on a topic of her choice to EJCI by the editor. She suggested this topic to ST and KM and wrote an initial outline for the paper. All authors then contributed iteratively and equally to the development of ideas and refinement of the paper.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Defining and conceptualising the commercial determinants of health

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention

              Alcohol, tobacco, and unhealthy foods contribute greatly to the global burden of non-communicable disease (NCD). Member states of the World Health Organization (WHO) have recognized the critical need to address these three key risk factors through global action plans and policy recommendations. The 2013-2020 WHO action plan identifies the need to engage economic, agricultural and other relevant sectors to establish comprehensive and coherent policy. To date one of the biggest barriers to action is not so much identifying affective policies, but rather how a comprehensive policy approach to NCD prevention can be established across sectors. Much of the research on policy incoherence across sectors has focused on exposing the strategies used by commercial interests to shape public policy in their favor. Although the influence of commercial interests on government decisions remains an important issue for policy coherence, we argue, that the dominant neoliberal policy paradigm continues to enable the ability of these interests to influence public policy. In this paper, we examine how this dominant paradigm and the way it has been enshrined in institutional mechanisms has given rise to existing systems of governance of product environments, and how these systems create structural barriers to the introduction of meaningful policy action to prevent NCDs by fostering healthy product environments. Work to establish policy coherence across sectors, particularly to ensure a healthy product environment, will require systematic engagement with the assumptions that continue to structure institutions that perpetuate unhealthy product environments.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Med (Lausanne)
                Front Med (Lausanne)
                Front. Med.
                Frontiers in Medicine
                Frontiers Media S.A.
                2296-858X
                22 September 2023
                2023
                : 10
                : 1247258
                Affiliations
                Division of Medical Ethics, Grossman School of Medicine, New York University , New York, NY, United States
                Author notes

                Edited by: Marc-Andre Gagnon, Carleton University, Canada

                Reviewed by: Mousumi Chaudhury, Agricultural Research Service (USDA), United States; Ana Marušić, University of Split, Croatia; Joel Lexchin, York University, Canada

                *Correspondence: Barbara K. Redman, bkredman@ 123456comcast.net
                Article
                10.3389/fmed.2023.1247258
                10556523
                37809337
                84ca359a-abb1-410d-8c37-529ed67d405d
                Copyright © 2023 Redman.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 25 June 2023
                : 06 September 2023
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 85, Pages: 12, Words: 11302
                Categories
                Medicine
                Policy and Practice Reviews
                Custom metadata
                Regulatory Science

                conflict of interest,commercial interests,public interests,environmental determinants of health,social determinants of health

                Comments

                Comment on this article